IBT
AXGN icon

International Biotechnology Trust’s Axogen AXGN Stock Holding History

International Biotechnology Trust’s Portfolio AXGN Stock Details AXGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-50,000
Closed -$1.82M – 57
2018
Q1 		$1.82M Buy
+50,000
New +$1.53M 0.71% 34

Other funds holding AXGN

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

International Biotechnology Trust's AXGN Position: Q2 2018 in Review

International Biotechnology Trust sold out of Axogen (AXGN) in Q2 2018, closing a stake of 50,000 shares — an estimated $1.82M sold.

International Biotechnology Trust first reported a position in AXGN in Q1 2018 and held it in 1 quarter. The position peaked at $1.82M in Q1 2018. 177 funds tracked by Wall St. Rank hold AXGN as of Q2 2018.

  • International Biotechnology Trust reported no remaining Axogen position as of Q2 2018 after selling out during the quarter.
  • International Biotechnology Trust sold 50,000 Axogen shares in Q2 2018, an estimated $1.82M.
  • International Biotechnology Trust first reported a position in Axogen in Q1 2018 and held it in 1 quarter.
  • International Biotechnology Trust's Axogen position peaked at $1.82M in Q1 2018.
  • 177 funds tracked by Wall St. Rank held Axogen as of Q2 2018.

Based on International Biotechnology Trust's 13F filing for Q2 2018, filed 13 Aug 2018.